Who
Thomas D. Salus
Chief Legal & Administration
Company insider
Files Form 4 as: Chief Legal & Administration, Lifecore Biomedical.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Apr 2025
- Last trade
- 14 Apr 2026
- Last filed
- 16 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Apr 2026filed 16 Apr 2026 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code F | $128K24,645 at $5.20 | filing |
| 14 Apr 2026filed 16 Apr 2026 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code F | $128K24,645 at $5.20 | filing |
| 2 Mar 2026filed 2 Mar 2026 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code A | —30,000 | filing |
| 2 Mar 2026filed 2 Mar 2026 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code A | —30,000 | filing |
| 8 Jul 2025filed 10 Jul 2025 | LFCR Lifecore Biomedicaloption or derivative · Biotechnology | SEC FORM 4 Code M | —37,000 | filing |
| 8 Jul 2025filed 10 Jul 2025 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code M | —37,000 | filing |
| 8 Jul 2025filed 10 Jul 2025 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code F | $90K11,022 at $8.19 | filing |
| 14 Apr 2025filed 16 Apr 2025 | LFCR Lifecore Biomedicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —370,000 at $0.00 | filing |
| 14 Apr 2025filed 16 Apr 2025 | LFCR Lifecore Biomedicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —210,000 at $0.00 | filing |
| 14 Apr 2025filed 16 Apr 2025 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code A | —45,000 | filing |
| 14 Apr 2025filed 16 Apr 2025 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code A | —170,000 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.